STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

How 1 sources are covering this

• STATCenter·1h ago

  STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

  A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.

  Read at STAT →